Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Pembrolizumab

Takotsubo cardiomyopathy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kaldas M, et al. An Interesting Case of Takotsubo Cardiomyopathy Associated with Checkpoint Immune Inhibitor. Journal of Cardiovascular Magnetic Resonance 26 (Suppl. 1): 653-654 abstr. Kiosk 9Q-FA-04, Jan 2024. Available from: URL: https://dx.doi.org/10.1016/j.jocmr.2024.100932 [abstract] Kaldas M, et al. An Interesting Case of Takotsubo Cardiomyopathy Associated with Checkpoint Immune Inhibitor. Journal of Cardiovascular Magnetic Resonance 26 (Suppl. 1): 653-654 abstr. Kiosk 9Q-FA-04, Jan 2024. Available from: URL: https://dx.doi.org/10.1016/j.jocmr.2024.100932 [abstract]
Metadaten
Titel
Pembrolizumab
Takotsubo cardiomyopathy
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58469-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe